ArticlemSphere2025

T and B cell responses following primary COVID-19 vaccination with CoronaVac and two heterologous BNT162b2 booster doses.

Apirath Wangteeraprasert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.